Source comparison
CJC-1295 Ipamorelin Protocol Recovery: Dosing Comparison
Acute Injury Recovery 200mcg 250–300mcg CJC 2×/week, Ipa daily before bed 6–8 weeks Post-surgical healing, ligament/tendon repair, fracture recovery Amplifies collagen synthesis during critical remodeling window. Clinical evidence strongest for this applicatio
This comparison does not assign a generated winner or score.
- Acute Injury Recovery
- 200mcg
- 250–300mcg
- CJC 2×/week, Ipa daily before bed
- 6–8 weeks
- Post-surgical healing, ligament/tendon repair, fracture recovery
- Amplifies collagen synthesis during critical remodeling window. Clinical evidence strongest for this application
- Chronic Overtraining Recovery
- 100–150mcg
- 200–250mcg
- CJC 1×/week, Ipa 5 days/week
- 8–12 weeks (after 2-week rest)
- Restoring blunted GH pulsatility in overtrained athletes
- Requires baseline HPA function restoration first. Peptides alone won't fix active overtraining syndrome
- General Performance Recovery
- 100mcg
- CJC 1×/week, Ipa 3–4×/week
- 8 weeks on, 4 weeks off
- Accelerating recovery between training blocks
- Moderate evidence for reduced DOMS and faster strength return. Less robust data than injury protocols
- Sleep Quality Enhancement
- 150–200mcg
- CJC 1×/week, Ipa nightly
- 4–6 weeks
- Improving slow-wave sleep duration in aging populations
- GH pulse amplitude correlates with SWS duration. Secondary benefit, not primary indication